+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Contrast Media/Agents Market Analysis by Modality (X-Ray/Computed Tomography, Magnetic Resonance Imaging), by Product, by Application, by Route of Administration, By Indications, and by Region - Global Forecast to 2029

  • PDF Icon

    Report

  • 147 Pages
  • May 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5614287
The global contrast media/agents market size is valued to be USD 4,979.4 million in 2021 and is projected to witness a CAGR of 3.98 % during the forecast period. Increasing incidence of cancer and cardiovascular diseases (CVDS) worldwide is a key driver for the growth of the global contrast media/agents market. Additionally, growth in demand related to prompt diagnosis and increase in number of CT and MRI examinations and development in favorable initiatives taken by government are some of the other drivers propelling the market growth. However, side-effects and allergic reactions to patients related with contrast agents and constraints and extraction of linear gadolinium-based contrast agents are expected to restrain the global market growth

By Modality


Based on modality, the market is segmented into ultrasound, X-ray/Computed Tomography (CT), and Magnetic Resonance Imaging (MRI). In 2021, the X-ray/computed tomography (CT) segment accounted for a substantial revenue share and is anticipated to grow with a lucrative CAGR during the forecast period. This is attributed to the widespread use of these products as they include barium-based and iodinated contrast agents that find application in various diagnostic procedures for several diseases worldwide. The MRI segment is expected to grow at a profitable CAGR during the forecast period. This is attributed to the extensive use of contrast agents to augment the contrast alteration between normal and abnormal tissues.

By Product


Based on product, the market is segmented into iodinated contrast media/contrast agents, barium-based contrast media/contrast agents, microbubble contrast media/contrast agents, and gadolinium-based contrast media/contrast agents. In 2021, the iodinated contrast media/contrast agents segment accounted for a substantial revenue share and is anticipated to grow with a lucrative CAGR during the forecast period. This is attributed to this product finding high application in CT examinations along with the fact that it can be used in nearly all body parts worldwide. Barium-based contrast media/contrast agents segment is projected to grow at a profitable CAGR during the forecast period. This is attributed to the increase in application of barium-based contrast media/contrast agents in imaging technology.

By Application


Based on application, the market is sub segmented as interventional cardiology, radiology, and interventional radiology. In 2021, the radiology segment accounted for a substantial revenue share and is anticipated to grow with a lucrative CAGR during the forecast period. This is due to the rising use of various contrast media/agents in the radiology segment to get a better diagnosis of various diseases worldwide. The interventional cardiology segment is anticipated to grow at a profitable CAGR during the forecast period, due to the increase in demand for minimally invasive surgical processes globally and rise in cases of cardiovascular diseases.

By Route of Administration


Based on route of administration, the market is categorized into intravascular, oral, rectal, and other routes. In 2021, the intravascular segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is due to developments in CT and MRI imaging technologies that are majorly used in the intravascular route to inoculate contrast media worldwide. The oral segment is anticipated to grow at a profitable CAGR during the forecast period due to the launch of new products and shift towards oral drugs are the key factors driving the market.

By Indications


Based on indications, the market is bifurcated as cardiovascular disorders, cancer, musculoskeletal disorders, neurological disorders, gastrointestinal disorders, and nephrological disorders. In 2021, the neurological disorders segment accounted for a substantial revenue share and is anticipated to grow with a lucrative CAGR during the forecast period. This is due to diagnostic assessment of CNS for neurological disorders, which is expected to boost the acceptance of MRI contrast media worldwide. The cancer segment is anticipated to grow at a profitable CAGR during the forecast period, due to the increase in need for prompt diagnosis owing to the rise in occurrence of the disease globally.

Regional Insights


In 2021, North America held the highest revenue share in the global market and is projected to sustain its dominance during the forecast period. This is attributed to the presence of major manufacturers in the region, increase in the share of healthcare expenditure in the per capita income, increase in research & development of new contrast agents in the market, and accessibility of technologically advanced products in the region. Asia Pacific market is expected to grow at the fastest CAGR over the forecast period owing to the less stringent regulations related to new product launches, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, and mergers & acquisitions by major market players in emerging economies. Competitor Insights Some of the key players in the contrast media/agents market are GE Healthcare (U.S.); Bracco Imaging (Italy); Bayer HealthCare (Germany); Guerbet (France); Lantheus (U.S.); Daiichi Sankyo (Japan); Unijules Life Sciences (India); J.B. Chemicals and Pharmaceuticals (India); Sanochemia (Austria); Taejoon Pharm (South Korea); Jodas (India); and Magnus Health (India). The leading players operating in the contrast media/agents industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The contrast media/agents market report is categorized into the following segments and subsegments:
Contrast Media/Agents Market, By Modality (Revenue, USD Million, 2021 - 2029)
  • Ultrasound
  • X-ray/Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
Contrast Media/Agents Market, By Product (Revenue, USD Million, 2021 - 2029)
  • Iodinated Contrast media/contrast agents
  • Barium-based Contrast media/contrast agents
  • Microbubble Contrast media/contrast agents
  • Gadolinium-based Contrast media/contrast agents
Contrast Media/Agents Market, By Application (Revenue, USD Million, 2021 - 2029)
  • Interventional Cardiology
  • Radiology
  • Interventional Radiology
Contrast Media/Agents Market, By Route of Administration (Revenue, USD Million, 2021 - 2029)
  • Intravascular
  • Oral
  • Rectal
  • Other Routes
Contrast Media/Agents Market, By Indications (Revenue, USD Million, 2021 - 2029)
  • Cancer
  • Cardiovascular Disorders
  • Musculoskeletal Disorders
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Nephrological Disorders
Contrast Media/Agents Market, By Region (Revenue, USD Million, 2021 - 2029)

North America

U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

South Africa
  • Saudi Arabia
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
1.4.1. Research Models
1.4.1.1. Bottom-up Approach
1.4.1.2. Top-down Approach
1.4.1.3. Data Triangulation
1.4.2. Data Procurement
1.4.2.1. Internal Database
1.4.2.2. Secondary Research
1.4.2.3. Purchased Database
1.4.2.4. Primary Research
1.4.3. Data Analysis
1.4.3.1. Data Validation
1.4.3.2. Market Size Estimation
1.4.3.3. Market Forecast Model
1.4.4. Quality Assessment
2. Introduction: Contrast Media/Agents
3. Executive Summary
3.1. Global Market Scenario
3.2. Segment Market Scenario
3.3. Geographic Market Scenario
3.4. COVID-19 Impact
3.5. Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4
5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. Value Chain Analysis
5.4. SWOT Analysis
5.5. Benchmark
6. COVID-19 Impact Analysis: Contrast Media/Agents Market
6.1. COVID-19: Overview
6.2. COVID-19 Impact on the Global Market
6.3. COVID-19 Impact on the Regional Markets
7. Market Analysis by Modality
7.1. Ultrasound
7.1.1. Ultrasound Market Forecast, 2020-2031 (USD Million)
7.2. X-ray/Computed Tomography (CT)
7.2.1. X-ray/Computed Tomography (CT) Market Forecast, 2020-2031 (USD Million)
7.3. Magnetic Resonance Imaging (MRI)
7.3.1. Magnetic Resonance Imaging (MRI) Market Forecast, 2020-2031 (USD Million)
8. Market Analysis by Product
8.1. Iodinated Contrast media/contrast agents
8.1.1. Iodinated Contrast media/contrast agents Market Forecast, 2020-2031 (USD Million)
8.2. Barium-based Contrast media/contrast agents
8.2.1. Barium-based Contrast media/contrast agents Market Forecast, 2020-2031 (USD Million)
8.3. Microbubble Contrast media/contrast agents
8.3.1. Microbubble Contrast media/contrast agents Market Forecast, 2020-2031 (USD Million)
8.4. Gadolinium-based Contrast media/contrast agents
8.4.1. Gadolinium-based Contrast media/contrast agents Market Forecast, 2020-2031 (USD Million)
9. Market Analysis by Application
9.1. Interventional Cardiology
9.1.1. Interventional Cardiology Market Forecast, 2020-2031 (USD Million)
9.2. Radiology
9.2.1. Radiology Market Forecast, 2020-2031 (USD Million)
9.3. Interventional Radiology
9.3.1. Interventional Radiology Market Forecast, 2020-2031 (USD Million)
10. Market Analysis by Route of Administration
10.1. Intravascular
10.1.1. Intravascular Market Forecast, 2020-2031 (USD Million)
10.2. Oral
10.2.1. Oral Market Forecast, 2020-2031 (USD Million)
10.3. Rectal
10.3.1. Rectal Market Forecast, 2020-2031 (USD Million)
10.4. Other Routes
10.4.1. Other Routes Market Forecast, 2020-2031 (USD Million)
11. Market Analysis by Indication
11.1. Cancer
11.1.1. Cancer Market Forecast, 2020-2031 (USD Million)
11.2. Cardiovascular Disorders
11.2.1. Cardiovascular Disorders Market Forecast, 2020-2031 (USD Million)
11.3. Musculoskeletal Disorders
11.3.1. Musculoskeletal Disorders Market Forecast, 2020-2031 (USD Million)
11.4. Gastrointestinal Disorders
11.4.1. Gastrointestinal Disorders Market Forecast, 2020-2031 (USD Million)
11.5. Neurological Disorders
11.5.1. Neurological Disorders Market Forecast, 2020-2031 (USD Million)
11.6. Nephrological Disorders
11.6.1. Nephrological Disorders Market Forecast, 2020-2031 (USD Million)
12. Regional Market Analysis
12.1. Regional Market Trends
12.2. Regional Market: Comparative Analysis
13. North America Contrast Media/Agents Market
13.1. North America Contrast Media/Agents Market
13.1.1. North America Market Size and Forecast, 2020-2031 (USD Million)
13.1.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
13.1.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
13.1.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
13.1.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
13.1.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
13.2. U. S. Contrast Media/Agents Market
13.2.1. U. S. Market Size and Forecast, 2020-2031 (USD Million)
13.2.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
13.2.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
13.2.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
13.2.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
13.2.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
13.3. Canada Contrast Media/Agents Market
13.3.1. Canada Market Size and Forecast, 2020-2031 (USD Million)
13.3.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
13.3.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
13.3.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
13.3.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
13.3.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
14. Europe Contrast Media/Agents Market
14.1. Europe Contrast Media/Agents Market
14.1.1. Europe Market Size and Forecast, 2020-2031 (USD Million)
14.1.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
14.1.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
14.1.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
14.1.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
14.1.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
14.2. Germany Contrast Media/Agents Market
14.2.1. Germany Market Size and Forecast, 2020-2031 (USD Million)
14.2.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
14.2.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
14.2.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
14.2.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
14.2.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
14.3. UK Contrast Media/Agents Market
14.3.1. UK Market Size and Forecast, 2020-2031 (USD Million)
14.3.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
14.3.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
14.3.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
14.3.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
14.3.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
14.4. France Contrast Media/Agents Market
14.4.1. France Market Size and Forecast, 2020-2031 (USD Million)
14.4.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
14.4.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
14.4.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
14.4.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
14.4.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
14.5. Spain Contrast Media/Agents Market
14.5.1. Spain Market Size and Forecast, 2020-2031 (USD Million)
14.5.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
14.5.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
14.5.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
14.5.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
14.5.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
14.6. Italy Contrast Media/Agents Market
14.6.1. Italy Market Size and Forecast, 2020-2031 (USD Million)
14.6.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
14.6.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
14.6.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
14.6.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
14.6.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
14.7. Rest of Europe Contrast Media/Agents Market
14.7.1. Rest of Europe Market Size and Forecast, 2020-2031 (USD Million)
14.7.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
14.7.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
14.7.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
14.7.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
14.7.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
15. Asia Pacific Contrast Media/Agents Market
15.1. Asia Pacific Contrast Media/Agents Market
15.1.1. Asia Pacific Market Size and Forecast, 2020-2031 (USD Million)
15.1.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
15.1.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
15.1.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
15.1.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
15.1.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
15.2. Japan Contrast Media/Agents Market
15.2.1. Japan Market Size and Forecast, 2020-2031 (USD Million)
15.2.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
15.2.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
15.2.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
15.2.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
15.2.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
15.3. China Contrast Media/Agents Market
15.3.1. China Market Size and Forecast, 2020-2031 (USD Million)
15.3.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
15.3.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
15.3.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
15.3.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
15.3.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
15.4. India Contrast Media/Agents Market
15.4.1. India Market Size and Forecast, 2020-2031 (USD Million)
15.4.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
15.4.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
15.4.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
15.4.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
15.4.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
15.5. South Korea Contrast Media/Agents Market
15.5.1. South Korea Market Size and Forecast, 2020-2031 (USD Million)
15.5.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
15.5.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
15.5.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
15.5.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
15.5.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
15.6. Australia Contrast Media/Agents Market
15.6.1. Australia Market Size and Forecast, 2020-2031 (USD Million)
15.6.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
15.6.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
15.6.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
15.6.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
15.6.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
15.7. Rest of Asia Pacific Contrast Media/Agents Market
15.7.1. Rest of Asia Pacific Market Size and Forecast, 2020-2031 (USD Million)
15.7.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
15.7.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
15.7.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
15.7.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
15.7.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
16. Latin America Contrast Media/Agents Market
16.1. Latin America Contrast Media/Agents Market
16.1.1. Latin America Market Size and Forecast, 2020-2031 (USD Million)
16.1.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
16.1.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
16.1.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
16.1.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
16.1.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
16.2. Brazil Contrast Media/Agents Market
16.2.1. Brazil Market Size and Forecast, 2020-2031 (USD Million)
16.2.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
16.2.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
16.2.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
16.2.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
16.2.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
16.3. Mexico Contrast Media/Agents Market
16.3.1. Mexico Market Size and Forecast, 2020-2031 (USD Million)
16.3.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
16.3.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
16.3.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
16.3.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
16.3.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
16.4. Argentina Contrast Media/Agents Market
16.4.1. Argentina Market Size and Forecast, 2020-2031 (USD Million)
16.4.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
16.4.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
16.4.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
16.4.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
16.4.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
16.5. Rest of Latin America Contrast Media/Agents Market
16.5.1. Rest of Latin America Market Size and Forecast, 2020-2031 (USD Million)
16.5.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
16.5.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
16.5.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
16.5.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
16.5.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
17. MEA Contrast Media/Agents Market
17.1. MEA Contrast Media/Agents Market
17.1.1. MEA Market Size and Forecast, 2020-2031 (USD Million)
17.1.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
17.1.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
17.1.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
17.1.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
17.1.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
17.2. GCC Contrast Media/Agents Market
17.2.1. GCC Market Size and Forecast, 2020-2031 (USD Million)
17.2.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
17.2.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
17.2.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
17.2.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
17.2.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
17.3. South Africa Contrast Media/Agents Market
17.3.1. South Africa Market Size and Forecast, 2020-2031 (USD Million)
17.3.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
17.3.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
17.3.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
17.3.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
17.3.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
17.4. Rest of MEA Contrast Media/Agents Market
17.4.1. Rest of MEA Market Size and Forecast, 2020-2031 (USD Million)
17.4.1.1. Market Size and Forecast by Modality, 2020-2031 (USD Million)
17.4.1.2. Market Size and Forecast by Product, 2020-2031 (USD Million)
17.4.1.3. Market Size and Forecast by Application, 2020-2031 (USD Million)
17.4.1.4. Market Size and Forecast by Route of Administration, 2020-2031 (USD Million)
17.4.1.5. Market Size and Forecast by Indication, 2020-2031 (USD Million)
18. Competitor Analysis
18.1. Market Share Analysis, 2021 & 2029
18.2. Competitive Mapping
18.3. Key Players Market Place Analysis
18.4. Major Recent Developments
19. Company Profiles
19.1. GE Healthcare (U. S.)
19.1.1. Company Snapshot
19.1.2. Company Overview
19.1.3. Financials
19.1.4. Modality Benchmarking
19.1.5. Recent Developments
19.2. Bracco Imaging (Italy)
19.2.1. Company Snapshot
19.2.2. Company Overview
19.2.3. Financials
19.2.4. Modality Benchmarking
19.2.5. Recent Developments
19.3. Bayer HealthCare (Germany)
19.3.1. Company Snapshot
19.3.2. Company Overview
19.3.3. Financials
19.3.4. Modality Benchmarking
19.3.5. Recent Developments
19.4. Guerbet (France)
19.4.1. Company Snapshot
19.4.2. Company Overview
19.4.3. Financials
19.4.4. Modality Benchmarking
19.4.5. Recent Developments
19.5. Lantheus (U. S.)
19.5.1. Company Snapshot
19.5.2. Company Overview
19.5.3. Financials
19.5.4. Modality Benchmarking
19.5.5. Recent Developments
19.6. Daiichi Sankyo (Japan)
19.6.1. Company Snapshot
19.6.2. Company Overview
19.6.3. Financials
19.6.4. Modality Benchmarking
19.6.5. Recent Developments
19.7. Unijules Life Sciences (India)
19.7.1. Company Snapshot
19.7.2. Company Overview
19.7.3. Financials
19.7.4. Modality Benchmarking
19.7.5. Recent Developments
19.8. J. B. Chemicals and Pharmaceuticals (India)
19.8.1. Company Snapshot
19.8.2. Company Overview
19.8.3. Financials
19.8.4. Modality Benchmarking
19.8.5. Recent Developments
19.9. Sanochemia (Austria)
19.9.1. Company Snapshot
19.9.2. Company Overview
19.9.3. Financials
19.9.4. Modality Benchmarking
19.9.5. Recent Developments
19.10. Taejoon Pharm (South Korea)
19.10.1. Company Snapshot
19.10.2. Company Overview
19.10.3. Financials
19.10.4. Modality Benchmarking
19.10.5. Recent Developments
19.11. Jodas (India)
19.11.1. Company Snapshot
19.11.2. Company Overview
19.11.3. Financials
19.11.4. Modality Benchmarking
19.11.5. Recent Developments
19.12. Magnus Health (India)
19.12.1. Company Snapshot
19.12.2. Company Overview
19.12.3. Financials
19.12.4. Modality Benchmarking
19.12.5. Recent Developments
19.13. PPD, Inc. (US)
19.13.1. Company Snapshot
19.13.2. Company Overview
19.13.3. Financials
19.13.4. Modality Benchmarking
19.13.5. Recent Developments
19.14. PAREXEL International Corporation (US)
19.14.1. Company Snapshot
19.14.2. Company Overview
19.14.3. Financials
19.14.4. Modality Benchmarking
19.14.5. Recent Developments
19.15. Almac Group (UK)
19.15.1. Company Snapshot
19.15.2. Company Overview
19.15.3. Financials
19.15.4. Modality Benchmarking
19.15.5. Recent Developments
19.16. Others Prominent Players
20. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • GE Healthcare (U.S.)
  • Bracco Imaging (Italy)
  • Bayer HealthCare (Germany)
  • Guerbet (France)
  • Lantheus (U.S.)
  • Daiichi Sankyo (Japan)
  • Unijules Life Sciences (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Sanochemia (Austria)
  • Taejoon Pharm (South Korea)
  • Jodas (India)
  • Magnus Health (India)